Sharps Technology, Inc. (NASDAQ:STSS) Sees Large Growth in Short Interest

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 428,100 shares, a growth of 356.4% from the January 15th total of 93,800 shares. Currently, 33.5% of the company’s stock are short sold. Based on an average trading volume of 1,250,000 shares, the days-to-cover ratio is presently 0.3 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Sharps Technology stock. Essential Planning LLC. lifted its position in shares of Sharps Technology, Inc. (NASDAQ:STSS) by 22.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 199,854 shares of the company’s stock after buying an additional 37,029 shares during the quarter. Essential Planning LLC. owned approximately 3.63% of Sharps Technology worth $412,000 at the end of the most recent quarter. Institutional investors own 17.17% of the company’s stock.

Sharps Technology Stock Down 1.9 %

NASDAQ STSS traded down $0.01 during trading hours on Thursday, reaching $0.37. The company’s stock had a trading volume of 4,677,314 shares, compared to its average volume of 2,899,177. Sharps Technology has a 1 year low of $0.30 and a 1 year high of $18.15. The business’s 50-day moving average is $1.59. The stock has a market cap of $2.01 million, a P/E ratio of -0.05 and a beta of 1.41.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.